International Journal of Biological Macromolecules, Год журнала: 2024, Номер 271, С. 132506 - 132506
Опубликована: Май 20, 2024
Язык: Английский
International Journal of Biological Macromolecules, Год журнала: 2024, Номер 271, С. 132506 - 132506
Опубликована: Май 20, 2024
Язык: Английский
Chemical Engineering Journal, Год журнала: 2025, Номер unknown, С. 160379 - 160379
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
0Fermentation, Год журнала: 2024, Номер 10(6), С. 275 - 275
Опубликована: Май 23, 2024
It is widely known that mushrooms present several properties with applications in the medicinal and pharmaceutical sectors, including antimicrobial, immunomodulatory, antioxidant, hypotensive, neuroprotective, anti-inflammatory activities. This article aims to review examples of bioactive metabolites responsible for those activities, such as polysaccharides, phenols polyphenols, terpenes, peptides, alkaloids, steroids, which are produced by relevant mushroom species. also discusses their production through solid-state fermentation submerged fermentation, well processes obtention extracts considerations on stability aiming industrial applications. In addition, examines patent landscape surrounding mushroom-derived bioactives, shedding light intellectual property history innovations driving this field forward. Examples recently deposited patents highlighted, main depositors. China United States major depositor countries (52% 35% patents, respectively), principal compounds polysaccharides alkaloids. The provides insights into current market landscape, showcasing products available consumers. From dietary supplements skincare formulations, offerings reflect growing interest harnessing health benefits bioactives.
Язык: Английский
Процитировано
4Chemical Engineering Journal, Год журнала: 2024, Номер 498, С. 155575 - 155575
Опубликована: Сен. 7, 2024
Язык: Английский
Процитировано
4International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(2), С. 663 - 663
Опубликована: Янв. 14, 2025
Organoid technology, as an innovative approach in biomedicine, exhibits promising prospects disease modeling, pharmaceutical screening, regenerative medicine, and oncology research. However, the use of tumor-derived Matrigel primary method for culturing organoids has significantly impeded clinical translation organoid technology due to concerns about potential risks, batch-to-batch instability, high costs. To address these challenges, this study innovatively introduced a photo-crosslinkable hydrogel made from porcine small intestinal submucosa decellularized matrix (SIS), fish collagen (FC), methacrylate gelatin (GelMA). The cost-effective demonstrated excellent biocompatibility, tunable mechanical properties, rapid gelation low immunogenicity. Importantly, proliferation differentiation capacities cultured were comparable those Matrigel, with no significant disparity observed. Furthermore, after one week transplantation nude mice, hydrogel-organoid complex exhibited sustained structural functional stability while preserving characteristics organoids. Our also effective FC/SIS/GelMA accelerating repair process defects, reducing area scar formation, promoting regeneration both villi smooth muscle tissue. In summary, presents novel protocol organoids, offering implications future applications serving experimental foundation development tissue-engineered intestines based on
Язык: Английский
Процитировано
0Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0International Journal of Biological Macromolecules, Год журнала: 2025, Номер unknown, С. 141834 - 141834
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0International Journal of Biological Macromolecules, Год журнала: 2024, Номер 271, С. 132506 - 132506
Опубликована: Май 20, 2024
Язык: Английский
Процитировано
0